Carregant...
Correcting oral contraceptive pharmacokinetic alterations due to obesity. A randomized controlled trial
OBJECTIVE: To determine if increasing the hormone dose or eliminating the hormone-free interval improves key pharmacokinetic (PK) alterations caused by obesity during oral contraceptive (OC) use. STUDY DESIGN: Obese (BMI ≥ 30 kg/m(2)), ovulatory, otherwise healthy, women received an OC containing 20...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4179976/ https://ncbi.nlm.nih.gov/pubmed/25070547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2014.06.033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|